- Press Release
- Pediatric Palliative Care Drugs Market to Surpass US$ 101.8 Billion by 2027
Pediatric Palliative Care Drugs Market to Surpass US$ 101.8 Billion by 2027 - Coherent Market Insights
Published On : Oct 21, 2020
Global Pediatric Palliative Care Drugs Market, By Drug Class (Analgesics, Anti‐emetics, Laxatives, Adjuvant Medications, Steroids, Sedatives, Neuroleptic Medications, and Others), By Route of Administration (Oral, Topical, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 71.8 billion in 2020 and is expected to exhibit a CAGR of 5.1% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
The companies are focusing on obtaining approvals for pediatric drugs from the regulatory authorities, in order to expand their product portfolio and strengthen their presence in the market, which is expected to drive growth of the pediatric palliative care drugs market over the forecast period. For instance, in October 2019, Novartis International AG received approval from the U.S. Food and Drug Administration (FDA) for Entresto, indicated for the treatment of symptomatic heart failure (HF) with systemic left ventricular systolic dysfunction in pediatric patients aged 1 year and older.
Global Pediatric Palliative Care Drugs Market – Impact of Coronavirus (Covid-19) Pandemic
The accessibility of palliative care inpatient and outpatient services as well as home visits have been seriously impacted by the COVID-19 pandemic. During the pandemic, the palliative care wards have set strict admission standards, which include:
Browse 35 Market Data Tables and 34 Figures spread through 198 Pages and in-depth TOC on “Pediatric Palliative Care Drugs Market”- Global Forecast to 2027, By Drug Class (Analgesics, Anti‐emetics, Laxatives, Adjuvant Medications, Steroids, Sedatives, Neuroleptic Medications, and Others), By Route of Administration (Oral, Topical, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).
To know the latest trends and insights prevalent in the global pediatric palliative care drugs market, click the link below:
https://www.coherentmarketinsights.com/market-insight/pediatric-palliative-care-drugs-market-4251
The rising incidence of congenital heart disease is also expected to propel growth of the pediatric palliative care drugs market. According to the Australian Institute of Health and Welfare (AIHW), around 5,000 hospitalizations with 1 among 3 infants of age under 1 year, suffering with congenital heart disease were recorded in Australia during 2016-2017.
Key Takeaways of the Global Pediatric Palliative Care Drugs Market:
Joining thousands of companies around the world committed to making the Excellent Business Solutions.